IL-2 is a well-characterized lymphokine that is responsible for growth or differentiation oflymphocytes. Intracellular signalings induced by IL-2 are transmitted via the surface IL-2R with a high affinity to IL-2 (1-3). The high affinity IL-2R has been demonstrated to be composed of at least two distinct subunits, IL-2Rp55 and IL-2Rp75, each of which contains an IL-2 binding site (4) (5) (6) (7) (8) . IL-2Rp55, with a molecular weight of 55 x 103 , is a so-called Tac antigen that has been defined by mAbs (9) (10) (11) and by its gene (12, 13) , and does not seem to contain any functional domain for signal transduction . IL-2Rp75, with molecular weights of 7-75 x 103, has been detected by chemical crosslinking with 125 I-labeled IL-2 (4-8). There is increasing evidence that the function of signal transduction is associated with IL2Rp75. IL-2 has induced intracellular signals for the stimulation ofcell growth (14) (15) (16) and phosphorylation of cellular proteins (17) in cells expressing IL-2Rp75 but not in those expressing IL-2Rp55 alone (14) (15) (16) . Furthermore, the internalization of IL-2 was mediated by the high-affinity IL-2R or IL-2Rp75 but not by the low affinity IL-2R, IL-2Rp55 (18) (19) (20) . Therefore, it is obvious that IL-2Rp75 can induce intracellular signals. However, the molecular nature of IL-2Rp75 and the mechanisms of signal transduction from IL-2R are still unknown. For investigation ofthese subjects, therefore, preparation of an mAb specific for IL-2Rp75 is desirable.
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Materials and Methods
Cell Lines and mAbs . The cell lines used here were seven human IL-2R' T cell lines carryinghuman T cell leukemia virus type I (HTLVI) (21) ; TL-Mor, MT 2, HUT102, ILTHir, ILTMat, TL-Hir, and MT-1, two nonhuman IL-2R' T cell lines; Gibbon ape MLA144 and murine CTLL-2, and three human IL-2R-cell lines; MOLT-4, Jurkat and HL-60. MT-2C41 is a subclone of MT-2, which expresses a large amount of the IL-2R. ILTHir, ILTMat, and CTLL-2 were maintained in RPMI-1640 medium supplemented with 10% FCS 2 HIM L-glutamine, antibiotics, and 1 nM human rIL-2 (obtained from Shionogi Co., Osaka, Japan) . The other cell lines were maintained in the RPMI-1640 medium without IL-2 . mAbs used as controls were two IgG1 mAbs specific for IL-2Rp55, H-31, and H-48 (10, 11) , and a IgG1 mAb, y-481, specific for the Sendai virus (provided by Dr. Tozawa, Kitasato University, Sagamihara, Japan) . 
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Preparation of a Hybridoma Producing an mAb. BALB/c mice were immunized intraperitoneally with 10' TL-Mor cells per mouse four times at weekly intervals. The TL-Mor cells used for immunization were pretreated with 1.0 ml sera of BALB/c mice hyperimmunized with three human cell lines negative for IL-2R: MOLT4, HPB-Null, and HL-60 . The sensitized spleen cells were fused with a mouse myeloma cell line, SP2/0-Ag14, and hybridoma cell clones were obtained as described previously (22) . More than 75,000 clones were screened for production of antibody by IL-2 binding blocking assays firstly with TL-Mor cells bearing IL-2Rp55 and IL-2Rp75 on microplates with vigorous washing, and secondly with MT-1 cells bearing only IL-2Rp55 in microtubes with sucrose cushion as reported previously (11, 18) . One clone producing an mAb that blocked the IL-2 binding to TL-Mor cells, but not to MT-1 cells, was isolated and recloned . Finally, the hybridoma cell line, derived from a single cell, was established and named TU27 . The class of antibody produced by TU27 is IgG1 .
Binding Assay of IL-2 and TU27 mAb . Human rIL-2 and purified TU27 mAb were radiolabeled with Na 1211 (Amersham Corp., Arlington Heights, IL) by the chloramine T method, and their binding assays for various cells were performed as described previously (11, 18) . In brief, 106 cells were incubated with '25 1-IL-2 (1.5 x 106 dpm/pmol) or '251 TU27 mAb (4 x 106 dpm/pmol) for 1.5 h at 4°C. The radioactivities in the supernatant and cells were measured separately. Their bindings were analyzed by Scatchard plots.
For 121 1-IL-2 binding blocking assays with mAbs, the cells were pretreated with 50 hg/ml ofmAb in RPMI-1640 medium containing 1 17c BSA, 25 mM Hepes and 0.02 % sodium azide for 1 h at 4°C before addition of IL-2 .
Inhibition of TU27 mAb Binding by IL-2 . 106 MT2C41 cells were incubated with various concentrations of IL-2 in 50 jl of RPMI-1640 medium containing 1% BSA, 25 mM Hepes, and 0.02% sodium azide at 4°C for 30 min, and then treated with 50 JAI of 1 nM 125 ITU27 mAb at 4°C for 1 h. The cells were precipitated in microtubes with 1 M sucrose cushion by centrifugation . The radioactivity associated with cells was counted and the number of binding sites of TU27 mAb was calculated from its specific radioactivity.
Affinity Labeling of Cells with 1251-IL-2. Affinity labeling of cells with 125 1-IL-2 was performed as reported previously (18) . In brief, 10' cells were preincubated for 1 h in the presence of 50 hg/ml of mAbs or 180 nM unlabeled IL-2 and further incubated with 0.1 nM or 5 nM 125 1-IL-2 for 1 h on ice . The cells were then treated with a chemical crosslinker, disuccinimidyl suberate (DSS Pierce Chemical Co., Rockford, IL), as reported by Sharon et al. (4) . The DSS-treated cells were solubilized in lysis buffer (300 nM NaCl, 50 mM Tris-HCI [pH 7 .4] and 0.5% NP-40) . Then the cell lysates were sujected to 7 .5% SDS-PAGE.
Radioimmunoprecipitation . 2-4 x 10' cells were radiolabeled with Na 1251 by using iodination reagent (IODO-GEN ; Pierce Chemical Co.) as described previously (23) . The radiolabeled cells were solubilized in 2 ml of buffer (25 mM Tris HCl [pH 7.5], 140 mM NaCl, 1 mM EDTA, 2 mM PMSF, 0.1% aprotinin, 0.5% NP-40), and appropriate aliquots were incubated with mAbs for 6 h. Then they were incubated with protein A-Sepharose pretreated with anti-mouse IgG for 4 h at 4°C. Immunoprecipitates bound to protein A-Sepharose were analyzed by 10% SDS-PAGE as described previously (23) .
Incorporation of [3H]Thymidine. IL-2-dependent ILTMat cells were washed three times with PBS, then preincubated for 8 h in the medium without IL-2, and delivered into 96-well microplates . Subsequently, mAb was added at a concentration of 50 l~g/ml, and then IL-2 diluted serially was added to the wells. The cells were incubated for 24 h at 370C under 7% C02 in air. During the last 4 h of incubation 1 ACi of [3H]TdR was added to each well. The incorporated [3H]TdR was counted as described elsewhere (24) .
Results
Cell lines were examined for the numbers of sites of high-and low-affinity IL-2R for IL-2 binding, and then for the numbers of binding sites ofTU27 mAb by Scatchard plot analyses . The results are shown in Table I . In all the cell lines bearing highaffinity IL-2R, the numbers of TU27 mAb binding sites were similar to those of high-affinity IL-2R. In MLA144 cells, which have been shown to express only IL- 2Rp75 with an intermediate affinity to IL-2 (5), the number of TU27 mAb binding sites was also similar to that of IL-2 binding sites. On the other hand, the TU27 mAb binding site was undetectable on MT-1 and TL-Hir cell lines, which bear only IL-2Rp55, and on three human T and monocytic cell lines, MOLT4, Jurkat, and HL-60, which are negative for IL-2R . A murine IL-2-dependent T cell line, CTLL-2, bearing both high-and low-affinity IL-2R, did not react with TU27 mAb either. These results indicate that TU27 mAb recognizes the antigen expressed on surfaces of human and Gibbon ape T cell lines bearing IL-2Rp75 .
The molecular mass of the antigen for TU27 mAb was determined by the SDS-PAGE ofradioimmunoprecipitation (Fig. 1) . TU27 mAb immunoprecipitated molecules with molecular masses of 71-81 kD (N75 kD) from lysates of 125 1-labeled ILT Mat, PHA-treated PBL, TL-Mor, MLA144, and MT-2 cells but not TL-Hir, Jurkat, and CTLL-2 cells, whereas H-31 mAb detected a band with an approximate molecular mass of 55 kD in the lysates of cells positive for IL-2Rp55, such as ILTMat and PBL cells.
To define further specificity of TU27 mAb, its effects on the IL-2 binding to cells were examined by chemical crosslinking with 125 1-IL-2 . MLA144, MT2, and TLHir cells preincubated in the presence or absence of TU27 mAb, H-31 mAb, y-481 mAb, or unlabeled IL-2 were further incubated with 125 1-IL-2, and then treated with a chemical crosslinker, DSS. The cell lysates were analyzed by the SDS-PAGE followed by autoradiography (Fig. 2) . TU27 mAb completely blocked the bindings of 125 1-IL-2 to the IL-2Rp75 of MLA144 and to IL-2Rp75 and IL-2Rp55 of MT-2 cells, but not the bindings to the IL-2Rp55 of TL-Hir cells. On the other hand, H-31 mAb specific for IL-2Rp55 completely blocked the binding to the IL-2Rp55 but not the IL-2Rp75 of these cells. As a control, unlabeled IL-2 blocked all the bindings of 125 1-IL-2 to IL-2Rp55 and IL-2Rp75 . Immunoprecipitation of 125I-labeled cell lysates with mAbs. Surfaces of cells indicated was labeled with Na 1 25 I, and their lysates were indirectly precipitated by TU27 mAb (a), .y-481 mAb as a negative control (6) , and H-31 mAb (c) . Immunoprecipitates were analyzed by 10% SDS-PAGE . PBL were stimulated with PHA for 1 d and then incubated with IL-2 for 2 d .
Furthermore, a Scatchard plot analysis of the IL-2 binding was performed in the presence ofTU27 mAb, H-31 mAb, or H-48 mAb (Fig. 3) . MT2C41 cells expressed both high affinity IL-2R (Kd = 57 pM, 2.1 x 104 sites/cell) and low-affinity IL-2R (Kd = 38 nM, 1.7 x 106 sites/cell). TU27 mAb completely blocked IL-2 binding to the high-affinity IL-2R but not to the low-affinity IL-2R. The low-affinity IL-2R detected in the presence of TU27 mAb was calculated at 2.1 x 106 sites/cell and 47 nM of Kd, which were not significantly different from those detected in the presence ofcontrol mAb. H-31 mAb, on the other hand, completely blocked IL-2 binding to both the high-and low-affinity IL-2R, but the intermediate-affinity IL-2R (Kd = 3.4 nM, 1.7 x 104 sites/cell) became detectable in the presence of H-31 mAb. Furthermore, the effect of IL-2 on 12 'ITU27 binding to MT=2C41 cells was also examined (Fig. 4) . When MT-2C41 cells were preincubated with IL-2, the 1211 TU27 mAb binding to the cells was blocked dose dependently by IL-2. 1.0 nM IL-2 almost completely inhibited the 1211 TU27 mAb binding. These observations suggest that TU27 mAb recognizes an epitope located near to the IL-2 binding site of IL-2Rp75, resulting in blocking of 125 1-IL-2 binding to IL-2Rp75 and impeding the composition of the high-affinity IL-2R.
Next, the effects of TU27 mAb on growth of IL-2-dependent ILTMat cells were examined by the [3H]TdR incorporation assay in the presence of various concentrations of IL-2 from 0 to 100 U/ml, and were compared with those of H-31 mAb (Fig . 5) . TU27 mAb partially inhibited the growth of ILTMat cells at low concentrations of IL-2, <11 U/ml . At a concentration of 1 U/ml of IL-2, ILTMat growth was inhibited up to 80 17o in the presence of concentrations of TU27 mAb from 11 to 100 ug/ml (Fig . 6 ) . Growth inhibition of 50% was seen at 2 ttg/ml of TU27 . Whereas H-31 mAb completely inhibited the growth at the low concentrations of IL-2, and partially inhibited at 11 and 33 U/ml of IL-2, but little inhibited it at 100 U/ml of IL-2 . However, combination of TU27 and H-31 mAbs induced almost complete inhibition of growth in the whole range of IL-2 doses (Fig . 5) . There are at least tnree bands that can be detected by the 125 1-IL-2 affinity labeling and crosslinking method ; they are the 55-kD molecule of IL-2Rp55, and the 75-and 70-kD molecules of IL-2Rp75 (7, 25) . MLA144 and YT cells are known to express the 75-and 70-kD molecules but not the 55-kD molecule, although the 75-and 70-kD molecules have often been detected as one band (4) (5) (6) . TU27 mAb immunoprecipitated a 75-kD molecule but not 70-kD molecule, which suggested a possibility that the 75-kD molecule is antigenically different from the 70-kD molecule, although it is still unclear whether these two molecules are related to each other in any way. The present study also suggested that the 75-kD molecule of IL-2Rp75 has an IL-2 binding site. However, we have not obtained any direct evidence that the 75-kD molecule precipitated with TU27 mAb was autophosphorylated (data not shown), suggesting that the 75-kD IL-2R molecule could be distinct from the class of receptors containing a tyrosine kinase.
It has been considered that the IL-2-mediated growth signal is transduced from the high-affinity IL-2R or the intermediate-affinity IL-2R but not from the low-affinity IL-2R, and that the IL-2Rp75 composing the high-and intermediate-affinity IL-2R is crucial for signal transduction (14) (15) (16) (17) (18) 20) . As TU27 mAb blocked IL-2 binding to IL-2Rp75 and to high-affinity IL-2R but not to low-affinity IL-2R, it was suspected that TU27 mAb inhibits IL-2-dependent growth ofcells or that it stimulates cell growth as an agonist of IL-2 . The IL-2-dependent growth of ILT Mat cells was significantly inhibited by TU27 mAb at low concentrations of IL-2, <11 U/ml, but not at high concentrations of IL-2, although the combination of TU27 and H-31 mAbs specific for IL-2Rp55 induced complete inhibition of it in the whole range of IL-2 doses up to 100 U/ml. In spite of the complete blocking of IL-2 binding to high-affinity IL-2R by TU27 mAb in the Scatchard plot analysis, TU27mAb did not completely inhibit the IL-2-dependent cell growth . This suggests two possibilities . One is that a difference exists in the ability ofTU27 mAb to block IL-2 binding between the Scatchard plot analysis at 4°C and the [3H]TdR incorporation assay at 37°C. Under the latter condition, IL-2Rp75, which can be newly synthesized, may bind IL-2 associated with IL-2Rp55 to compose the high-affinity IL-2R . In such a case, TU27 mAb would not be able to block the IL-2 binding because of its lower binding affinity (Kd = 2 .1 nM) to the high-affinity IL-2R (Kd = 28 pM) which could be efficiently composed of a large amount of IL-2 associated with IL2Rp55 expressed on cell surface. The other possibility is that the IL-2-mediated growth signal could be transduced not only from the high-affinity IL-2R but also from the low-affinity IL-2R of ILTMat cells in the presence ofTU27 mAb . There is a report describing that L cells transfected with the IL-2Rp55 gene were stimulated to incorporate [3H]TdR by IL-2 (26), although IL-2 has not been found to induce any intracellular signaling in cell lines expressing only the low-affinity IL-2R, IL-2Rp55, in other reports (17, 27, 28) . To determine which of the above possibilities for signal transduction from IL-2R, further characterization of the molecular nature of IL2Rp75 is required. Our new mAb, TU27 mAb, should be useful for such studies . Summary A mouse hybridoma cell line, TU27, producing an mAb was established . TU27 mAb reacted with various human and Gibbon ape T cell lines bearing the IL-2R p75 (IL-2Rp75), but not with cell lines expressing only Tac antigen, IL-2Rp55, and numbers of its binding sites on cell surfaces were similar to those of high-affinity IL-2R. Radioimmunoprecipitation with TU27 mAb defined a molecule with a molecular mass of 75 kD on the surface of IL-2Rp75 bearing cells. TU27 mAb completely blocked IL-2 binding to IL-2Rp75 and to the high-affinity IL-2R but not to IL-2Rp55 composing the low-affinity IL-2R . The IL-2-dependent growth of a human T cell line, ILT Mat, was significantly inhibited by TU27 mAb only at low concentrations of IL-2, and combination of TU27 mAb and H-31 mAb specific for IL-2Rp55 completely inhibited the cell growth even at high concentrations of IL-2. These data strongly suggest that TU27 mAb is specific for the human IL-2Rp75 .
Received for publication 28 September 1988 and in revised form 29 December 1988 .
